Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Søren Ottosen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|December 16, 2014
[Visual symptoms by syphilis]Søren K O Abildgaard, Søren Ottosen, Kirsten Lau Baggesen, et al.
Acta Ophthalmologica|January 28, 2012
Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in DenmarkTomas Ilginis, Søren Ottosen, Kristian Harbo Bundsgaard, et al.
Virology|November 22, 2005
Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sitesSøren Ottosen, Francisco J Herrera, James R Doroghazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2008
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodiesJeffrey N Savas, Anthony Makusky, Søren Ottosen, et al.
Molecular and Cellular Biology|February 4, 2009
Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1Shahram Misaghi, Søren Ottosen, Anita Izrael-Tomasevic, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122Søren Ottosen, Todd B Parsley, Lu Yang, et al.
Hepatology (Baltimore, Md.)|October 27, 2018
PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA StabilizationHenrik Mueller, Anaïs Lopez, Philipp Tropberger, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|December 16, 2014
[Visual symptoms by syphilis]Søren K O Abildgaard, Søren Ottosen, Kirsten Lau Baggesen, et al.
Acta Ophthalmologica|January 28, 2012
Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in DenmarkTomas Ilginis, Søren Ottosen, Kristian Harbo Bundsgaard, et al.
Virology|November 22, 2005
Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sitesSøren Ottosen, Francisco J Herrera, James R Doroghazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2008
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodiesJeffrey N Savas, Anthony Makusky, Søren Ottosen, et al.
Molecular and Cellular Biology|February 4, 2009
Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1Shahram Misaghi, Søren Ottosen, Anita Izrael-Tomasevic, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122Søren Ottosen, Todd B Parsley, Lu Yang, et al.
Hepatology (Baltimore, Md.)|October 27, 2018
PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA StabilizationHenrik Mueller, Anaïs Lopez, Philipp Tropberger, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
Pageof 1